More than 300 current and former biotech and pharmaceutical executives have signed an open letter criticizing a federal Texas judge over his recent decision to suspend FDA approval of the abortion pill mifepristone. “We cannot stay quiet. We call for the reversal of this decision to disregard science, and the appropriate restitution of the mandate…